Clinical Trials Sponsored by Instituto Nacional de Cancerologia de Mexico

Total 2295 results

Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung | Synchronous Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Results From a Mexican Acute Promyelocytic Leukemia. (Mexico APL)

Promyelocytic Leukemia, Acute

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma

EGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Quality of Life | Breast Neoplasm | Antineoplastic Agents | Antiemetics

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care (PACO)

Lung Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Anorexia | Non-Small Cell Lung Cancer | Cachexia | Weight Lose

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Non-small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIB

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations (METLUNG)

Non Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

Ovarian Cancer | Chemotherapy Effect | HPEC | Women's Health: Neoplasm of Ovary

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

Quality of Life | Sarcopenia | Pulmonary Rehabilitation

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Lung Cancer | Sarcopenia | Toxicity

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Lung Neoplasms | Small Cell Lung Carcinoma | Non-Small Cell Lung Cancer | Taste Disorders | Dysgeusia

Mexico
Instituto Nacional de Cancerologia de Mexico

Terminated

Study of Whole-brain Irradiation With Chloroquine for Brain Metastases (CLQ)

Brain Metastasis

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis (PCI)

Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia

Anorexia | Non-small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Active, not recruiting

Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery (AEROBIKA)

Lung Cancer | Mediastinal Tumor | Pleural Tumor

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients (SPIROCAN)

Cancer | Critically Ill

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment

Brain Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Non-Hodgkin Lymphoma

Mexico
Instituto Nacional de Cancerologia de Mexico
AstraZeneca

Completed

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

Breast Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Enfermedades Respiratorias

Recruiting

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Pneumonitis

Mexico
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Completed

Alectinib in Combination With Bevacizumab in ALK Positive NSCLC

ALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of Lung

Mexico
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Active, not recruiting

Tocilizumab Treatment in Patients With COVID-19

Sars-CoV2

Mexico
Metropolitan Autonomous University
Instituto Nacional de Cancerologia de Mexico

Unknown

Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate

Mucositis

Mexico
Instituto Nacional de Cancerologia de Mexico
National Council of Science and Technology, Mexico

Unknown

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Advanced Malignant Pleural Mesothelioma

Mexico
Instituto Nacional de Cancerologia de Mexico
National Council of Science and Technology, Mexico

Completed

Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation

Radiation; Adverse Effect, Pneumonitis

Mexico
Oscar Gerardo Arrieta Rodríguez

Recruiting

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Lung Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Locally Advanced Malignant Neoplasm

Mexico
National Institute of Cancerología
Kimberly-Clark de México

Unknown

Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation

Surgical Site Infection

Mexico
Hospital General San Juan del Rio
Instituto Nacional de Cancerologia de Mexico

Completed

Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 (APRONOX)

Pneumonia | COVID | ARDS

Mexico
Instituto Nacional de Cancerologia, Columbia

Completed

Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms

Uterine Cervical Neoplasms
Instituto Nacional de Cancerologia, Columbia

Withdrawn

Curcumin in Advanced Cervical Cancer

Cervical Cancer, Stage IIB
Instituto Nacional de Cancerologia, Columbia

Active, not recruiting

Human Papilloma Virus (HPV) Self-collection and Women Adherence

Cervical Cancer | HPV Infection

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Thyroid Cancer

Colombia
Instituto Nacional de Cancerologia, Columbia

Terminated

Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer

Colorectal Surgery | Colonic Neoplasms | Ileostomy - Stoma

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Neuroendocrine Tumors

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

ROLL vs WGLL for Non-palpable Breast Lesions (ROLLvsWGLL)

Breast Cancer
National Institute of Cancerología
Instituto Nacional de Rehabilitacion

Completed

Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial

Breast Cancer

Mexico
National Polytechnic Institute, Mexico
Instituto Nacional de Salud Publica, Mexico; Universidad Nacional Autonoma... and other collaborators

Unknown

Effects of COcoa Supplement in OBese Adolescent Subjects (COOBA)

Childhood Obesity | Adolescent Obesity
Instituto Nacional de Cancerologia, Columbia

Unknown

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer

Mexico

Clinical Trials Sponsored by Instituto Nacional de Cancerologia de Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations